转移性阴膜黑色素瘤的新兴治疗策略:准驱动突变
Xiao-Lian Liu1,2, Zhou Run-Hua2, Jing-Xuan Pan3
1Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pigment cell & melanoma research
|February 27, 2024
概括
转移性脑膜黑色素瘤 (UM) 是一种致命的癌症,治疗方法很少. 本综述强调了针对UM具有特定突变的新型向疗法和表观遗传策略,并探索了与免疫治疗的组合.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 卵巢黑色素瘤 (UM) 是最常见的成年人初级眼内恶性瘤.
- 虽然初级UM通常是可以控制的,但超过40%的转移,经常转移到肝脏,导致预后不佳.
- 转移性UM具有有限的治疗选择.
研究的目的:
- 审查转移性UM的新兴向和表观遗传疗法.
- 探索将这些策略与免疫治疗结合在一起的潜力.
- 专注于与正在进行或即将进行的临床试验相关的治疗方法.
主要方法:
- 目前关于皮膜黑色素瘤病原和治疗的文献综述.
- 对包括GNAQ/GNA11,BAP1和SF3B1突变在内的遗传驱动因素的分析.
- 检查下游通路 (PKC/MAPK,PI3K/AKT/mTOR,Hippo-YAP) 和它们的治疗影响.
主要成果:
- 激活GNAQ或GNA11中的突变可以启动UM.
- 同时发生在BAP1或SF3B1中的突变对于恶性进展至关重要.
- 临床前研究确定了BAP1损失和SF3B1突变的可操作目标.
结论:
- 向治疗和表观遗传策略对转移性UM有希望.
- 目前正在研究包括免疫疗法在内的组合方法.
- 临床试验正在评估针对特定UM遗传特征的新型治疗策略.
更多相关视频
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
1.7K
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
1.4K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
